Brachytherapy – an update on current UK practice

18th September 2020  13:30 - 16:45 (GMT+01:00) Europe/London

This event is going virtual!

Virtual event- Friday 18 September 13:30-16:45 BST

This exciting half-day virtual event will provide updates for best practice for gynaecological and prostate brachytherapy from leading clinicians in the field. Radiotherapy experts will explain the best way to plan these treatments. Furthermore, an overview of emerging techniques / treatment accuracy / safety will be presented.

Who should attend?: Oncologists / therapy radiographers / radiotherapy physicist of all grades from trainees to consultants.

Educational aims:

  • To be aware of current best practice for gynaecological brachytherapy
  • To be aware of the current most likely causes of errors and incidents in brachytherapy in the UK
View full virtual event programme

Call for abstracts

We are inviting researchers to submit abstracts (up to 400 words) for ePoster and/or proffered/YouTube clip presentation relating to brachytherapy. These can be on any aspect of brachytherapy. Please indicate upon submission of your abstract if you are submitting for an ePoster or proffered/YouTube clip presentation. YouTube clips (max 10 mins) will be uploaded onto the BIR website for access by meeting delegates.  Please visit the Call for abstracts webpage for more information and to submit your abstract. 

Submission deadline: 5pm Friday 21 August 2020

Registration fees:

EARLY BIRD Registration fees*:

BIR members FREE
Non members £60
*Early bird rates expire 21 August 2020

Registration fees*:
BIR members FREE
Non members £80

*VAT added at checkout

A special thank you for the support on this virtual event

OSL - To find out further information on OSL range of brachytherapy products click here
Varian - Please click here to see more information on Varian | BRAVOS




Advanced Accelerator Applications

Advanced Accelerator Applications, S.A. (AAA), a Novartis company, is an innovative medicines company developing targeted radioligand therapies and precision imaging radioligands for oncology. We are committed to transforming patients’ lives by leading innovation in nuclear medicine. AAA currently has over 1,000 employees working across 31 sites in 12 countries (Canada, France, Germany, Israel, Italy, the Netherlands, Poland, Portugal, Spain, Switzerland, the UK and the US). The company also has global manufacturing capabilities with 19 facilities in eight countries, and six research & development sites. For more information, please visit:


Bayer’s Radiology business is well placed to be the partner of choice in helping NHS trusts to address the many challenges faced today including the increasing need for governance to demonstrate best practice and improving patient care within increasing financial constraints. With market-leading contrast media and power injector systems, Bayer is able to offer innovative patient care and with the addition of its informatics platform, it can support radiology departments in driving protocol standardisation and easily accessible audit data that enable departments to meet further challenges faced around contrast and radiation dose management. 0118 2063999

Elekta Ltd

GE Healthcare Ltd

GE Healthcare is a leading provider of medical imaging, monitoring, and life science technologies. GE Healthcare enables precision health in diagnostics, therapeutics and monitoring through intelligent devices, data analytics, applications and services to help providers, researchers and life sciences companies in their mission to improve outcomes for patients around the world.

Oncology Systems Limited

Oncology Systems Limited (OSL) is a leading, independent provider of medical equipment and software to the NHS and private hospitals in the UK, Ireland and worldwide. Our products are cutting edge and innovative, and our support is delivered by experts, ultimately enabling clinicians to practice the highest quality therapies for the treatment of cancer.

Philips Healthcare

Enabling better health and better care at lower cost Philips is a leading health technology company focused on improving people`s lives across the health continuum - from healthy living and prevention, to diagnosis, treatment and home care. Applying advanced technologies and deep clinical and consumer insights, Philips delivers integrated solutions that improve people`s health and enable better outcomes. Partnering with its customers, Philips seeks to transform how healthcare is delivered and experienced. The company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care.

Siemens Healthineers

At Siemens Healthineers, our purpose is to enable healthcare providers to increase value by empowering them on their journey towards expanding precision medicine, transforming care delivery, and improving patient experience, all enabled by digitalising healthcare. An estimated 5 million patients globally everyday benefit from our innovative technologies and services in the areas of diagnostic and therapeutic imaging, laboratory diagnostics and molecular medicine, as well as digital health and enterprise services. We are a leading medical technology company with over 170 years of experience and 18,000 patents globally. With more than 48,000 dedicated colleagues in 75 countries, we will continue to innovate and shape the future of healthcare. For more information and latest product line, please visit

Varian Medical Systems UK Ltd